114 related articles for article (PubMed ID: 2935907)
1. [Calcium antagonists in the therapy of essential arterial hypertension. Analysis of the results obtained with 3 drugs].
Bossini A; Di Veroli C; Amoroso A
Recenti Prog Med; 1985 Oct; 76(10):505-14. PubMed ID: 2935907
[No Abstract] [Full Text] [Related]
2. [Nitrendipine, a new calcium antagonist, as basis therapy in essential hypertension].
Groth H; Stimpel M; Edmonds D; Mosca R; Vetter W
Schweiz Rundsch Med Prax; 1985 May; 74(19):503-6. PubMed ID: 3160097
[No Abstract] [Full Text] [Related]
3. Crossover comparison of nitrendipine with propranolol in patients with essential hypertension.
Fritschka E; Distler A; Gotzen R; Thiede HM; Philipp T
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1100-4. PubMed ID: 6085375
[TBL] [Abstract][Full Text] [Related]
4. Nitrendipine in hypertension that is difficult to control.
Höffler D; Stoepel K
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1060-2. PubMed ID: 6085367
[TBL] [Abstract][Full Text] [Related]
5. Nitrendipine and atenolol: comparison and combination in the treatment of arterial hypertension.
de Divitiis O; Petitto M; Di Somma S; Galderisi M; Villari B; Santomauro M; Fazio S
Arzneimittelforschung; 1985; 35(4):727-9. PubMed ID: 3160356
[TBL] [Abstract][Full Text] [Related]
6. Long-term effectiveness of BAY e 5009-nitrendipine in the treatment of mild and moderate arterial hypertension.
Esper RJ; Esper RC; Baglivo HP; Castro JM; Rohwedder RW; Menna J
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1096-9. PubMed ID: 6085374
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive effects on blood pressure at rest and during exercise of calcium antagonists, beta-receptor blockers, and their combination in hypertensive patients.
Franz IW; Wiewel D
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1037-42. PubMed ID: 6085363
[TBL] [Abstract][Full Text] [Related]
8. [Verapamil and nitrendipine in beta blocker-resistant hypertensive patients].
Edmonds D; Förster E; Wehling M; Siegenthaler W; Vetter W
Schweiz Rundsch Med Prax; 1985 May; 74(19):510-3. PubMed ID: 3160098
[No Abstract] [Full Text] [Related]
9. Large arteries in hypertension: acute effects of a new calcium entry blocker, nitrendipine.
Levenson J; Simon AC; Safar ME; Bouthier J; Maarek BC
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1006-10. PubMed ID: 6085357
[TBL] [Abstract][Full Text] [Related]
10. Calcium antagonists for antihypertensive baseline therapy. First International Nitrendipine Symposium. Interlaken, April 13-14, 1984.
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S929-1113. PubMed ID: 6085378
[No Abstract] [Full Text] [Related]
11. Are there any relevant differences within the calcium antagonist class?
Trimarco B
Int J Clin Pract Suppl; 2000 Nov; (114):6-9. PubMed ID: 11221295
[No Abstract] [Full Text] [Related]
12. Efficacy of nitrendipine as baseline antihypertensive therapy.
Rüddel H; Schmieder R; Langewitz W; Neus J; Wagner O; von Eiff AW
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1049-52. PubMed ID: 6085365
[TBL] [Abstract][Full Text] [Related]
13. Place of calcium antagonists in antihypertensive therapy: introduction and round-table discussion.
Bühler FR; Distler A; Laragh JH; Tourkantonis D; Valdes G; Weber MA
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S929-32. PubMed ID: 6085379
[No Abstract] [Full Text] [Related]
14. [Treatment of arterial hypertension with a calcium-channel blocking agent, nicardipine hydrochloride].
Cascone A; Ferrari F; Alaimo A; Daprati A; Cascone G
Boll Chim Farm; 1985 May; 124(5):37S-42S. PubMed ID: 4052244
[No Abstract] [Full Text] [Related]
15. Acute and long-term effects of nitrendipine on resting and exercise hemodynamics in essential hypertension.
Nannan ME; Melin JA; Vanbutsele RJ; Lavenne F; Detry JM
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1043-8. PubMed ID: 6085364
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive effect of a new calcium channel blocker, FK 235, in essential hypertension.
Mizuno K; Hashimoto S; Yabe R; Kunii N; Niimura S; Tani M; Watari H; Fukuchi S
Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):3-15. PubMed ID: 3520729
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with long-term nitrendipine treatment in essential hypertension.
Tourkantonis A; Lasaridis A; Settas L
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1090-5. PubMed ID: 6085373
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of nitrendipine in patients with severe hypertension: a multiclinic study.
Jain AK; McMahon FG; Ryan JR; Maronde R; Vlachakis N; Mroczek W
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1053-9. PubMed ID: 6085366
[TBL] [Abstract][Full Text] [Related]
19. Renal effects of nitrendipine monotherapy in essential hypertension.
Thananopavarn C; Golub MS; Eggena P; Barrett JD; Sambhi MP
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1032-6. PubMed ID: 6085362
[TBL] [Abstract][Full Text] [Related]
20. Safety aspects of long-term nitrendipine therapy.
Stoepel K; Deck K; Corsing C; Ingram C; Vanov SK
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1063-6. PubMed ID: 6085368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
